Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash and Cash Equivalents $ 5,400,498 $ 5,964,556
Prepaid Expenses and Other Current Assets 239,391 343,069
Tax Receivables 1,343,087 1,373,041
Total Current Assets 6,982,976 7,680,666
Non-Current Assets:    
Property and Equipment, Net 38,616 55,177
Restricted Cash 4,031 49,260
Intangible Assets and In-Process R&D, Net 8,820,100 10,743,164
Operating Lease Assets with Right-of-Use 18,725 116,992
Other Assets 31,995 33,000
Total Assets 15,896,443 18,678,259
Current Liabilities:    
Accounts Payable 125,412 1,008,262
Accrued Expenses 1,461,711 1,835,934
Operating Lease Liabilities 18,725 105,782
Contingent Consideration, short-term 495,000 322,385
Total Current Liabilities 2,100,848 3,272,363
Non-Current Liabilities:    
Contingent Consideration 5,002,505 3,309,175
Deferred Tax Liability 689,121 689,121
Total Non-Current Liabilities 5,691,626 3,998,296
Total Liabilities 7,792,474 7,270,659
Commitments and Contingencies (Notes 9 and 10)
Stockholders’ Equity:    
Preferred Stock, $0.01 Par Value: 10,000,000 shares authorized 5 0
Common Stock, $0.01 Par Value: 50,000,000 shares authorized; 7,689,240 and 1,796,472 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 76,915 17,986
Additional Paid-In Capital 153,001,469 146,035,314
Accumulated Deficit (144,708,249) (134,462,959)
Accumulated Other Comprehensive Loss (266,171) (182,741)
Total Stockholders’ Equity 8,103,969 11,407,600
Total Liabilities and Stockholders’ Equity $ 15,896,443 $ 18,678,259